Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group.

Author: BadeschD B, BarstR J, BlackburnS D, BourgeR C, BrundageB H, ClaytonL M, CrowJ W, GrovesB M, HinderliterA L, JöbsisM M, KellerC A, KochG, KoernerS K, LanglebenD, LiS, LongW A, McGoonM D, MuraliS, RichS, RubinL J, TapsonV F, UretskyB F, WillisP W

Paper Details 
Original Abstract of the Article :
Right heart failure is an important cause of morbidity and mortality in primary pulmonary hypertension. In a recent prospective, randomized study of severely symptomatic patients, treatment with prostacyclin (epoprostenol) produced improvements in hemodynamics, quality of life, and survival. This ar...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1161/01.cir.95.6.1479

データ提供:米国国立医学図書館(NLM)

Easing the Burden of Pulmonary Hypertension: The Promise of Prostacyclin

Pulmonary hypertension, a condition that affects the heart and lungs, can be a debilitating and life-threatening illness. This research focuses on the use of prostacyclin (epoprostenol), a drug that helps relax blood vessels, to improve the quality of life and survival of patients with severe primary pulmonary hypertension. The researchers conducted a prospective, randomized study to evaluate the effectiveness of long-term prostacyclin infusion, meticulously analyzing echocardiographic measures of right ventricular structure and function.

Hope on the Horizon: Prostacyclin's Potential for Pulmonary Hypertension

This study offers a beacon of hope for those living with pulmonary hypertension. The researchers found that prostacyclin therapy produced significant improvements in hemodynamics, quality of life, and survival. This promising result underscores the potential of prostacyclin as a valuable therapeutic option for patients with this challenging condition.

Living Well with Pulmonary Hypertension: A Journey of Hope and Resilience

While pulmonary hypertension can be a difficult diagnosis, this study provides a glimmer of hope. The improved quality of life and survival observed in patients receiving prostacyclin therapy highlights the importance of early diagnosis and effective treatment. This research encourages patients to actively engage in their healthcare and embrace a journey of hope and resilience.

Dr. Camel's Conclusion

This research, like a cool oasis in the desert, offers hope and relief for those living with the challenges of pulmonary hypertension. The use of prostacyclin therapy demonstrates the power of medical innovation in improving patient outcomes. We continue to journey towards a future where this debilitating condition is better understood and effectively managed.

Date :
  1. Date Completed 1997-04-24
  2. Date Revised 2022-03-17
Further Info :

Pubmed ID

9118516

DOI: Digital Object Identifier

10.1161/01.cir.95.6.1479

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.